Concepedia

Luc Van Nueten

LV

48

Publications

3.9K

Citations

33

H-Index

1992

Active since

Affiliations

Janssen (Belgium)(Current)

Janssen (United States)

University of Antwerp

KU Leuven

Centre for Human Drug Research

Luc Van Nueten is an author at Janssen (Belgium) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1992–2023

48

Publications

48

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

Ella Daly, Jaskaran Singh, Maggie Fedgchin et al. · JAMA Psychiatry · 2017 · 670 citations · Full text

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

Jaskaran Singh, Maggie Fedgchin, Ella Daly et al. · American Journal of Psychiatry · 2016 · 511 citations · Full text

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

Jaskaran Singh, Maggie Fedgchin, Ella Daly et al. · Biological Psychiatry · 2015 · 435 citations · Full text

Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.

J.R. Cockcroft, Phil Chowienczyk, Sally Brett et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 325 citations

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study

Maarten Timmers, Johannes Streffer, Alberto Russu et al. · Alzheimer s Research & Therapy · 2018 · 106 citations · Full text

Rows per page

1–5 of 48